Manchester Score for Prognosis in Small Cell Lung Cancer

Loading...

Serum LDH > upper limit of normal

Serum Na < 132 mmol/L

Serum alk phos > 1.5x the upper limit of normal

Serum bicarbonate < 24

Extensive stage disease

Karnofsky Performance Status

Referencias

R. Hagmann. Validation of Pretreatment Prognostic Factors and Prognostic Staging Systems for Small Cell Lung Cancer in a Real-World Data Set. Cancers, 2022
A-M C Dingemans. Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆.. Annals of oncology : official journal of the European Society for Medical Oncology, 2021
E. Higgins. Chemoradiotherapy with radical intent for small cell lung cancer (SCLC): A 5 year retrospective review: 93P. Journal of Thoracic Oncology, 2016
Alyson L Mahar. Refining Prognosis in Lung Cancer: A Report on the Quality and Relevance of Clinical Prognostic Tools.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2015
M. Paesmans. Validation and comparison of several published prognostic systems for patients with small cell lung cancer. European Respiratory Journal, 2011